42
PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
PRE-MEETING COURSES
Radiobiology track
CLINICAL APPLICATION OF NEWCOMBINATIONS: HOWTO TEST AND OPTIMISE
NOVEL BIOLOGICAL AGENTS IN COMBINATIONWITH RADIOTHERAPY
09:15 - 17:00 | LONDRA
Course Directors: A. Chalmers (UK) and D. Zips (Germany)
09:15
INTRODUCTION AND OVERVIEW
Course Director: A. Chalmers (UK)
09:30
INTRINSIC CELLULAR TARGETS, INCLUDING THE DNA DAMAGE
RESPONSE AND ONCOGENIC SIGNALLING PATHWAYS
A. Chalmers (UK)
10:00
TUMOUR MICROENVIRONMENT TARGETS, INCLUDING HYPOXIA,
VASCULATURE AND THE IMMUNE SYSTEM
R. Bristow (Canada)
10:30
COFFEEBREAK
11:00
PRECLINICAL EVALUATION OF NOVEL DRUG-RADIOTHERAPY
COMBINATIONS: IN VITRO AND EARLY IN VIVO TESTING
Teacher: C. Vens (The Netherlands)
11:30
PRECLINICAL EVALUATION OF NOVEL DRUG-RADIOTHERAPY
COMBINATIONS: COMPLEX IN VIVOMODELS
Teacher: M. Baumann (Germany)
12:00
CLINICAL TRIAL DESIGN: INCLUDING DOSE SELECTION, DOSE
ESCALATION AND BIOMARKER DRIVEN STUDY DESIGNS
Teacher: P. Lambin (The Netherlands)
12:30
DISCUSSION
13:00
LUNCH
14:00
MOLECULAR BIOMARKERS FOR OPTIMISATION OF NOVEL
RADIOTHERAPY-DRUG COMBINATIONS
Teacher: D.G. Duda (USA)
14:30
IMAGING BIOMARKERS FOR OPTIMISATION OF NOVEL
RADIOTHERAPY-DRUG COMBINATIONS
Course Director: D. Zips (Germany)
15:00
COFFEEBREAK